Evidence map›Paper›PMID 31632982›Full record

ArticleFrontiers in molecular biosciences2019

The Role of Post-translational Modifications on the Energy Landscape of Huntingtin N-Terminus.

Havva Yalinca, Charlotte Julie Caroline Gehin, Vladimiras Oleinikovas, Hilal A Lashuel, Francesco Luigi Gervasio, Annalisa Pastore

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Amino acid homorepeats in proteins.Nature reviews. Chemistry · 2020
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Havva YalincaDepartment of Chemistry, University College London, London, United Kingdom.
Charlotte Julie Caroline GehinLaboratory of Molecular and Chemical Biology of Neurodegeneration, Faculty of Life Sciences, Brain Mind Institute, EPFL, Lausanne, Switzerland.
Vladimiras OleinikovasDepartment of Chemistry, University College London, London, United Kingdom.
Hilal A LashuelLaboratory of Molecular and Chemical Biology of Neurodegeneration, Faculty of Life Sciences, Brain Mind Institute, EPFL, Lausanne, Switzerland.
Francesco Luigi GervasioDepartment of Chemistry, University College London, London, United Kingdom.
Annalisa PastoreKing's College London, London, United Kingdom.

Funding

Medical Research Council MC_U117584256
6 · The paper itself

Abstract

Huntington disease is a neurodegenerative disease characterized by a polymorphic tract of polyglutamine repeats in exon 1 of the huntingtin protein, which is thought to be responsible for protein aggregation and neuronal death. The polyglutamine tract is preceded by a 17-residue sequence that is intrinsically disordered. This region is subject to phosphorylation, acetylation and other post-translational modifications

Indexed as

enhanced samplingHuntington's diseasemisfolding diseasemolecular dynamicspeptide foldingphosphorylationpost-translational modifications

Identifiers

PMID31632982
PMCPMC6779701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.